New Cervical Cancer Screening Method is More Accurate Than Pap Smears
A new screening method for cervical cancer risk may replace the uncomfortable, dreaded Pap smear, according to a study published in JAMA. Testing for cancer-related human papillomavirus (HPV), which causes 99.7 percent of cervical cancer, outperformed the effectiveness of Pap smears in women over the age of 30.
Testing for HPV is a less intrusive method for cancer screening. Instead of a physician scraping the cells from the back of a woman’s cervix before visually inspecting them for signs of abnormality, an HPV test analyzes cells found in vaginal and cervical secretions.
“Primary HPV testing of women detects precancerous lesions earlier, and more accurately than the Pap test,” said the authors in a statement. Generally speaking, women who had the Pap smear were more than twice as likely to have abnormal cells; HPV testing resulted in 22 cases whereas the Pap smear had 52 women with abnormal cells.
Story Source and image source: IFL Science
Originally written by: Nada El Garhy
Note: Content may be edited for style and length